在保留射血分数的心力衰竭临床试验中，循环利尿剂作为风险标志的效用：来自瑞典心力衰竭登记处的分析

IF 16.9 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

European Journal of Heart Failure Pub Date : 2025-01-23 DOI:10.1002/ejhf.3578

Fouad Chouairi, Marat Fudim, Gianluigi Savarese, Barna Szabo, Ulf Dahlström, Camilla Hage, Federica Guidetti, Lina Benson, Lars H. Lund

{"title":"在保留射血分数的心力衰竭临床试验中，循环利尿剂作为风险标志的效用：来自瑞典心力衰竭登记处的分析","authors":"Fouad Chouairi, Marat Fudim, Gianluigi Savarese, Barna Szabo, Ulf Dahlström, Camilla Hage, Federica Guidetti, Lina Benson, Lars H. Lund","doi":"10.1002/ejhf.3578","DOIUrl":null,"url":null,"abstract":"It is common in heart failure (HF) trials, especially in HF with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF), to select for increased risk of outcomes (‘enrichment’). We investigated the association between loop diuretic use and common trial outcomes.","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"300 1","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry\",\"authors\":\"Fouad Chouairi, Marat Fudim, Gianluigi Savarese, Barna Szabo, Ulf Dahlström, Camilla Hage, Federica Guidetti, Lina Benson, Lars H. Lund\",\"doi\":\"10.1002/ejhf.3578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is common in heart failure (HF) trials, especially in HF with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF), to select for increased risk of outcomes (‘enrichment’). We investigated the association between loop diuretic use and common trial outcomes.\",\"PeriodicalId\":164,\"journal\":{\"name\":\"European Journal of Heart Failure\",\"volume\":\"300 1\",\"pages\":\"\"},\"PeriodicalIF\":16.9000,\"publicationDate\":\"2025-01-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ejhf.3578\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3578","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

在心力衰竭（HF）试验中，特别是保留（HFpEF）和轻度射血分数降低（HFmrEF）的心力衰竭（HF）试验中，选择风险增加的结局（“富集”）是很常见的。我们调查了循环利尿剂使用与常见试验结果之间的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry

It is common in heart failure (HF) trials, especially in HF with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF), to select for increased risk of outcomes (‘enrichment’). We investigated the association between loop diuretic use and common trial outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Heart Failure 医学-心血管系统

CiteScore

27.30

自引率

11.50%

发文量

365

审稿时长

1 months

期刊介绍： European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.